{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:53:09Z","timestamp":1791103989249,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd004524.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,2,28]],"date-time":"2013-02-28T00:00:00Z","timestamp":1362009600000}}],"reference-count":41,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004524.pub4","type":"journal-article","created":{"date-parts":[[2013,2,23]],"date-time":"2013-02-23T06:21:01Z","timestamp":1361600461000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Methotrexate for ankylosing spondylitis"],"prefix":"10.1002","volume":"2013","author":[{"given":"Junmin","family":"Chen","sequence":"first","affiliation":[{"name":"The First Affiliated Hospital of Fujian Medical University; Department of Hematology and Rheumatology; #20 Chazhong Road Fuzhou Fujian Province China 350005"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirella MS","family":"Veras","sequence":"additional","affiliation":[{"name":"University of Ottawa; Centre for Global Health, Institute of Population Health; 1 Stewart street Ottawa Ontario Canada K1N 6N5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Liu","sequence":"additional","affiliation":[{"name":"The First Hospital of Hebei Medical University; Donggang Road Shijiazhuang Hebei Province China 050031"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfang","family":"Lin","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Fujian Medical University; Department of Hematology and Rheumatology; #20 Chazhong Road Fuzhou Fujian Province China 350005"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,2,28]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD004524.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/030097401753180318","article-title":"Clinical investigation of methotrexate in the treatment of ankylosing spondylitis","volume":"30","author":"Altan","year":"2001","journal-title":"Scandinavian Journal of Rheumatology"},{"issue":"8","key":"10.1002\/14651858.CD004524.pub4-BIB0002|cit2","first-page":"1568","article-title":"Efficacy of methotrexate in ankylosing spondylitis: a randomized, double blind, placebo controlled trial","volume":"31","author":"Gonzalez-Lopez","year":"2004","journal-title":"The Journal of Rheumatology"},{"issue":"11","key":"10.1002\/14651858.CD004524.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/rheumatology\/41.11.1330","article-title":"Is methotrexate effective in ankylosing spondylitis?","volume":"41","author":"Roychowdhury","year":"2002","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004524.pub4-BIB0004|cit4","first-page":"43","article-title":"Methotrexate in severe ankylosing spondylitis: a randomised placebo controlled, double-blind observer study","volume":"40","author":"Roychowdhury","year":"2001","journal-title":"Rheumatology"},{"issue":"1","key":"10.1002\/14651858.CD004524.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/art.23167","article-title":"Maintenance of infliximab treatment in ankylosing spondylitis: results of a one-year randomized controlled trial comparing systematic versus on-demand treatment","volume":"58","author":"Breban","year":"2008","journal-title":"Arthritis and Rheumatism"},{"issue":"Suppl 9","key":"10.1002\/14651858.CD004524.pub4-BIB0006|cit6","first-page":"S214","article-title":"No superiority of infliximab (INF) + methotrexate (MTX) over INF alone in the treatment of ankylosing spondylitits (AS): results of a one-year randomized prospective study","volume":"52","author":"Breban","year":"2005","journal-title":"Arthritis and Rheumatism"},{"issue":"12","key":"10.1002\/14651858.CD004524.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s00296-009-1057-6","article-title":"Efficacy of SLZ and MTX (alone or combinaiton) on the treatment of sacroiliitis in early AS","volume":"29","author":"Kabasakal","year":"2009","journal-title":"Rheumatology International"},{"issue":"9","key":"10.1002\/14651858.CD004524.pub4-BIB0009|cit8","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/rheumatology\/ken207","article-title":"Short-term efficacy of combination methotrexate and infliximab in patients with ankylosing spondylitis: a clinical and magnetic resonance imaging correlation","volume":"47","author":"Li","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1002\/14651858.CD004524.pub4-BIB0008|cit9","first-page":"1423","article-title":"Short-term efficacy of combination methotrexate and infliximab in patients with ankylosing spondylitis: a clinical and magnetic resonance imaging correlation. Erratum","volume":"49","author":"Li","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1002\/14651858.CD004524.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"R82","DOI":"10.1186\/ar3350","article-title":"Infliximab in ankylosing spondylitis: alone or in combination with methotrexate? A pharmacokinetic comparative study","volume":"13","author":"Mulleman","year":"2011","journal-title":"Arthritis Research and Therapy"},{"issue":"3","key":"10.1002\/14651858.CD004524.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jbspin.2006.08.005","article-title":"Increased efficacy of infliximab associated with methotrexate in ankylosing spondylitis","volume":"74","author":"P\u00e9rez-Guijo","year":"2007","journal-title":"Joint Bone Spine"},{"issue":"5","key":"10.1002\/14651858.CD004524.pub4-BIB0012|cit12","first-page":"460","article-title":"Methotrexate in conjunction with meloxicam for treating ankylosing spondylitis: a clinical observation of the efficacy and safety","volume":"23","author":"Xie","year":"2003","journal-title":"Di Yi Jun Yi Da Xue Xue Bao (Academic journal of the First Medical College of PLA)"},{"issue":"2","key":"10.1002\/14651858.CD004524.pub4-BIB0013|cit13","first-page":"56","article-title":"Prospective, nonblind trial of methotrexate on seronegative spondyloarthropathy","volume":"14","author":"Haque","year":"1999","journal-title":"Journal of Institute of Postgraduate Medicine and Research"},{"issue":"2","key":"10.1002\/14651858.CD004524.pub4-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/art.10148","article-title":"Guidelines for the management of rheumatoid arthritis","volume":"46","author":"American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines","year":"2002","journal-title":"Arthritis and Rheumatism"},{"issue":"12","key":"10.1002\/14651858.CD004524.pub4-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1002\/art.21492","article-title":"Overestimation of the prevalence of ankylosing spondylitis in the Berlin study: comment on the article by Braun et al","volume":"52","author":"Akkoc","year":"2005","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD004524.pub4-BIB0016|cit16","first-page":"4","article-title":"The burden of ankylosing spondylitis","volume":"78","author":"Boonen","year":"2006","journal-title":"The Journal of Rheumatology. Supplement"},{"issue":"2","key":"10.1002\/14651858.CD004524.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s100670050027","article-title":"Efficacy of methotrexate in the treatment of ankylosing spondylitis: a three-year open study","volume":"19","author":"Biasi","year":"2000","journal-title":"Clinical Rheumatology"},{"issue":"2","key":"10.1002\/14651858.CD004524.pub4-BIB0018|cit18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004800.pub2","article-title":"Sulfasalazine for ankylosing spondylitis","author":"Chen","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004524.pub4-BIB0019|cit19","first-page":"45","article-title":"Methotrexate in the treatment of ankylosing spondylitis","volume":"37","author":"Clavaguera","year":"1998","journal-title":"British Journal of Rheumatology"},{"issue":"6","key":"10.1002\/14651858.CD004524.pub4-BIB0020|cit20","first-page":"1104","article-title":"Methotrexate in severe ankylosing spondylitis: an open study","volume":"22","author":"Creemers","year":"1995","journal-title":"Journal of Rheumatology"},{"issue":"3","key":"10.1002\/14651858.CD004524.pub4-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/ard.2006.054098","article-title":"No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16-week open-label trial","volume":"66","author":"Haibel","year":"2007","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"2","key":"10.1002\/14651858.CD004524.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/anr.1780320221","article-title":"Favourable results using methotrexate in the treatment of patients with ankylosing spondylitis","volume":"32","author":"Handler","year":"1989","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD004524.pub4-BIB0023|cit23","unstructured":"Higgins J Altman DG Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.2 (updated September 2009. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"4","key":"10.1002\/14651858.CD004524.pub4-BIB0024|cit24","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008495","article-title":"Methotrexate monotherapy versus methotrexate combination therapy with non-biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis","author":"Katchamart","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"Suppl 59","key":"10.1002\/14651858.CD004524.pub4-BIB0025|cit25","first-page":"57","article-title":"Efficacy and side effects of low dose methotrexate treatment in the patients with ankylosing spondylitis","volume":"27","author":"Kirnap","year":"2000","journal-title":"Journal of Rheumatology"},{"issue":"9","key":"10.1002\/14651858.CD004524.pub4-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1002\/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W","article-title":"Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis","volume":"41","author":"Maini","year":"1998","journal-title":"Arthritis and Rheumatism"},{"issue":"28","key":"10.1002\/14651858.CD004524.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta11280","article-title":"Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation","volume":"11","author":"McLeod","year":"2007","journal-title":"Health Technology Assessment"},{"issue":"5","key":"10.1002\/14651858.CD004524.pub4-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1053\/berh.2002.0263","article-title":"Seronegative spondyloarthritides","volume":"16","author":"Olivieri","year":"2002","journal-title":"Best Practice and Research. Clinical Rheumatology"},{"issue":"3","key":"10.1002\/14651858.CD004524.pub4-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00124743-199806000-00007","article-title":"Methotrexate lacks efficacy in the treatment of severe ankylosing spondylitis compared with rheumatoid and psoriatic arthritis","volume":"4","author":"Ostendorf","year":"1998","journal-title":"Journal of Clinical Rheumatology"},{"issue":"3","key":"10.1002\/14651858.CD004524.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jbspin.2006.08.005","article-title":"Increased efficacy of infliximab associated with methotrexate in ankylosing spondylitis.","volume":"74","author":"Perez-Guijo","year":"2007","journal-title":"Joint Bone Spine"},{"key":"10.1002\/14651858.CD004524.pub4-BIB0031|cit31","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2012"},{"issue":"3","key":"10.1002\/14651858.CD004524.pub4-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/030097400750002021","article-title":"Methotrexate in the treatment of ankylosing spondylitis","volume":"29","author":"Sampaio-Barros","year":"2000","journal-title":"Scandinavian Journal of Rheumatology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD004524.pub4-BIB0033|cit33","first-page":"ii1","article-title":"The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis","volume":"68","author":"Sieper","year":"2009","journal-title":"Annal of the Rheumatic Diseases"},{"issue":"6","key":"10.1002\/14651858.CD004524.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/ard.2009.126532","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs","volume":"69","author":"Smolen","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"2","key":"10.1002\/14651858.CD004524.pub4-BIB0035|cit35","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000957","article-title":"Methotrexate for treating rheumatoid arthritis","author":"Suarez-Almazor","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD004524.pub4-BIB0036|cit36","first-page":"945","article-title":"Which domains should be included in a core set for endpoints in ankylosing spondylitis? Introduction to the ankylosing spondylitis module of OMERACT IV","volume":"26","author":"Heijde","year":"1999","journal-title":"The Journal of Rheumatology"},{"key":"10.1002\/14651858.CD004524.pub4-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"iii24","DOI":"10.1136\/ard.61.suppl_3.iii24","article-title":"Treatment trials in ankylosing spondylitis: current and future considerations","volume":"61(Suppl 3)","author":"Heijde","year":"2002","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"2","key":"10.1002\/14651858.CD004524.pub4-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/art.20790","article-title":"Assessment in Ankylosing Spondylitis International Working Group\/Spondylitis Association of America recommendations for conducting clinical trials in ankylosing spondylitis","volume":"52","author":"Heijde","year":"2005","journal-title":"Arthritis and Rheumatism"},{"issue":"3","key":"10.1002\/14651858.CD004524.pub4-BIB0039|cit39","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005468","article-title":"TNF-alpha inhibitors for ankylosing spondylitis","author":"Zochling","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD004524.pub4-BIB0040|cit40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004524.pub2","article-title":"Methotrexate for ankylosing spondylitis","author":"Chen","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD004524.pub4-BIB0041|cit41","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004524.pub3","article-title":"Methotrexate for ankylosing spondylitis","author":"Chen","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD004524.pub4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T04:47:14Z","timestamp":1736398034000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004524.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Musculoskeletal Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,2,28]]},"references-count":41,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004524.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,28]]}}}